Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001789769-22-000055
Filing Date
2022-05-25
Accepted
2022-05-25 18:08:05
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165351647029928.html 4  
1 FORM 4 wf-form4_165351647029928.xml 4 4077
  Complete submission text file 0001789769-22-000055.txt   5448
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INSTIL BIO, INC. 3963 MAPLE AVENUE, SUITE 350 DALLAS TX 75219
Business Address
Chiruvolu Vijay (Reporting) CIK: 0001851347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40215 | Film No.: 22964386